SDM-RCC 研究的目的是评估综合共享决策 (SDM) 干预对肾细胞癌 (RCC) 患者决策过程和结果的影响。干预措施包括在线患者决策辅助 (PtDA) 以及对医疗保健专业人员 (HCP) 使用 PtDA 和 SDM 的培训。该研究是在荷兰六家医院开展的一项多中心、前瞻性前测-后测队列研究，重点关注局部或转移性肾细胞癌患者。主要结果是观察到的决策过程质量，使用 OPTION-5 分数进行衡量。次要结果包括决策过程的感知质量、决策质量和干预措施的实施（用户统计数据和访谈）。对问卷数据进行定量分析，对访谈数据进行定性分析，并根据既定框架进行编码。研究结果可以从患者、HCP 和观察者的角度增进对 RCC 患者决策过程的理解。所实施的 SDM 工具预计将支持决策过程。患者摘要：我们正在开展一项试验，研究一种工具的效果，以支持面临治疗决策的肾癌患者共同决策。本文概述了将用于试验的方案。版权所有 © 2024。由 Elsevier B.V. 出版。

The aim of the SDM-RCC study is to evaluate the impact of a comprehensive shared decision-making (SDM) intervention for patients with renal cell carcinoma (RCC) on the decision-making process and outcomes. The intervention includes online patient decision aids (PtDAs) and training of health care professionals (HCPs) in the use of PtDAs and SDM. The study is a multicenter, prospective pretest-posttest cohort in six Dutch hospitals, focusing on patients with localized or metastatic RCC. The primary outcome is the observed quality of the decision-making process, measured using OPTION-5 scores. Secondary outcomes include perceived quality of the decision-making process, decision quality, and implementation of the intervention (user statistics and interviews). Quantitative analysis will be performed on questionnaire data, while qualitative analysis will be performed on interviews using coding based on established frameworks. The study results could improve understanding of the decision-making process for RCC patients from patient, HCP, and observer perspectives. The SDM tool implemented is expected to support the decision-making process. PATIENT SUMMARY: We are conducting a trial on the effects of a tool to support shared decision-making by patients with kidney cancer who are facing treatment decisions. This paper outlines the protocol that will be used for the trial.Copyright © 2024. Published by Elsevier B.V.